EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer

Kamuran Inci iD, Bengt Nilsson, Stefan Lindskog, Daniel Giglio iD

ANZ Journal of Surgery · 2023

DOI: 10.1111/ans.18629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2023. Verfasst von Kamuran Inci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Halland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies show conflicting results on whether primary tumour resection (PTR) in metastatic colorectal cancer (mCRC) prolongs survival. The aim of this study was to analyse prognostic factors and the effects of PTR on overall survival (OS) in mCRC patients.

Methods

In this population‐based cohort study, factors associated with PTR and OS were assessed in 188 mCRC patients with mCRC treated with palliative chemotherapy between 2008 and 2019. The Chi‐square test and Mann–Whitney U ‐test were used to assess factors associated with PTR. The log‐rank test was used to compare Kaplan–Meier estimates for OS. Cox regression was used to identify factors predicting OS.

Results

Patients undergoing PTR had significantly better performance status, fewer metastatic sites, lower CEA levels, and more often had left‐sided CRC than patients not undergoing PTR. OS was longer in palliative mCRC patients undergoing PTR ( P < 0.01) and PTR was an independent variable in the Cox regression analysis ( P < 0.05). Median OS was 22.9 ± 1.9 months for the PTR group and 14.5 ± 1.5 months for the non‐operated group. Poor performance status and liver metastases were significantly associated with poor prognosis.

Conclusion

This study shows that PTR had a positive effect on OS and may be considered in patients suitable for surgery. PTR was offered to palliative mCRC patients with prognostic factors associated with better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsColonic NeoplasmsRectal NeoplasmsHumansCohort StudiesRetrospective StudiesPrognosis

Stichwörter der Autor:innen

colorectal cancermetastaticpalliativepalliative resectionsurgerysurvival

Autor:innen und Institutionen

  • Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Department of Surgery, Region Halland, Varberg, Sweden.
  • Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.

ORCID-Profile: Kamuran Inci, Daniel Giglio

Förderung

  • Region Halland

Zitieren

APA

Inci, K., Nilsson, B., Lindskog, S., & Giglio, D. (2023). Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18629

Vancouver

Inci K, Nilsson B, Lindskog S, Giglio D. Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer. ANZ Journal of Surgery. 2023. doi:10.1111/ans.18629

BibTeX
@article{Inci2023,
  author = {Inci, Kamuran and Nilsson, Bengt and Lindskog, Stefan and Giglio, Daniel},
  title = {Palliative resection of the primary tumour improves survival in incurable metastatic colorectal cancer},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  doi = {10.1111/ans.18629}
}
Kostenlos starten →